Wednesday, april 20, 2022

Capio Group Services AB has received all necessary regulatory approvals concerning the recommended cash offer to the shareholders of GHP Specialty Care AB

  • SHARE ON
  • twitter
  • facebook
  • linkedin

On March 7, 2022, Capio Group Services AB (“Capio”), which is a wholly-owned subsidiary of Capio AB (publ) and part of the Ramsay Santé Group, announced a recommended public offer to the shareholders of GHP Specialty Care AB (“GHP”) to tender all shares in GHP to Capio at a price of SEK 35 in cash per share (the “Offer”). An offer document relating to the Offer was published on March 23, 2022.

ramsay sante.png
Capio has received necessary merger control approval in Sweden and approval required under applicable Danish foregin direct investment legislation. As a result, Capio has received all necessary regulatory approvals. Hence, the condition for Capio’s completion of the Offer relating to the receipt of necessary regulatory approvals has been satisfied. All other conditions set out in the offer document, including conditions for the completion of the Offer, are still applicable.

The offer document and other information concerning the offer are available on the transaction website (www.healthcare-nordic.com/en) and on Nordea Bank Abp, filial i Sverige’s (“Nordea”) website (www.nordea.se/prospekt).

About Ramsay Santé

After the acquisition of the Capio Group in 2018, Ramsay Santé has become the leading European provider of comprehensive healthcare services. The group now has 36,000 employees and works with nearly 8,600 private practitioners.

Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 facilities.

In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres.

The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS).

The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.

Wednesday, april 20, 2022
  • SHARE ON
  • twitter
  • facebook
  • linkedin
Contact
    Henrik Brehmer
    Chief Strategy & Public Affairs Officer
    Telephone: +46 76 111 34 14
    Email:
Last Releases
  • Monday, december 12, 2022
    The Board of Directors of Ramsay Générale de Santé renews Pascal Roché as Chief Executive Officer [View press release]
  • Wednesday, december 7, 2022
    Preventive health gains ground in France according to the prevention barometer conducted by Odoxa for Ramsay Santé [View press release]
  • Thursday, november 10, 2022
    Ramsay Santé Q1 results at september 30, 2022 [View press release]
  • Friday, november 4, 2022
    Living Labs: Ramsay Santé strengthens its healthcare innovation strategy [View press release]
  • Thursday, october 13, 2022
    Annual results at end June 2022 [View press release]
View all releases